InnoCare Pharma Ltd. (HK:9969) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InnoCare Pharma Ltd. has received a one-month waiver from the Hong Kong Stock Exchange to appoint a new independent non-executive director, following the recent resignation of Dr. Kaixian Chen. The company is working to finalize the appointment by the end of January 2025, after facing procedural delays. This move aims to ensure compliance with stock exchange listing rules.
For further insights into HK:9969 stock, check out TipRanks’ Stock Analysis page.